Skip to main content
. 2017 Apr 18;15:86. doi: 10.1186/s12957-017-1148-x

Fig. 1.

Fig. 1

Tumor evolution on MRI. ac MRIs during tamoxifen + arthrocine association (tumoral volume respectively 27.4, 27.1, and 30.4 cm3). df MRIs during sorafenib (tumoral volume respectively 24.7, 26.5, and 25.6 cm3). g MRI during IFN (tumoral volume 26.4 cm3). h, i MRIs during sunitinib (tumoral volumes respectively 15.3 and 13.2 cm3)